These results suggest that the mechanism of signal transduction through IL-13 and IL-4 receptors in human fibroblast cell lines is similar, and this may, at least in part, be responsible for the redundant effects of these two cytokines. In addition, JAK2 tyrosine kinase instead of JAK3 appears to play a major role in IL-4-and IL-13-induced signal transduction in human fibroblasts.
Introduction
IL-13 has been shown to share some biological properties with IL-4 (1). On human fibroblasts, both IL-4 and IL-13 have predominant effects (2) (3) (4) (5) . For biological effects to occur, these ligands interact with their plasma membrane receptors. The receptors for IL-4 (IL-4R) have been studied extensively. The first subunit was identified as a 140 kDa protein (termed here IL-4Rβ) (6) . The second subunit was shown to be the IL-2Rγ c chain (termed γ c ) (7, 8) , and recently we (9, 10) and other groups (11) have proposed that the 60-70 kDa protein form of IL-13R may also participate in the function of IL-4R experiments demonstrated that the IL-13RαЈ but not the IL-13Rα chain is a novel component of the IL-4R system (13) . We and others have also demonstrated that the primary IL-4 binding protein IL-4Rβ (p140) is also a part of IL-13R system in certain cell types (12, 14) . Thus, IL-4R shares two chains with the IL-13R system. Recently, two different types of human IL-13 receptor chains have been cloned (15, 16) . We have identified these proteins as IL-13Rα and IL-13RαЈ chains. Thus, IL-13R can be categorized in three or four different types. In type I IL-13R, IL-13Rα and IL-13RαЈ may form a complex and IL-13 does not bind significantly to IL-4Rβ chain. In type II IL-13R, only IL-13RαЈ and IL-4Rβ is expressed and IL-13 binds to both proteins. In type III or IV receptors, in addition to IL-13RαЈ and IL-4Rβ chains, the IL-2Rγ chain may modulate IL-13 binding (12, 17) . Additional reconstitution experiments are underway to define the exact structure of the IL-13R system. For signal transduction, Janus (JAK) kinase-signal transduction and activator of transcription (STAT) and insulin response substrate (IRS)-1 pathways are activated in response to IL-4 or IL-13 in various cell types (10, (18) (19) (20) (21) (22) (23) . In hematopoietic cells (TF-1 cells), contrary to IL-4, IL-13 can induce phosphorylation of JAK1 and Tyk2 but not JAK3 tyrosine kinase (22) . We have reported that IL-13 induces phosphorylation of Tyk2 in Epstein-Barr virusimmortalized human B cell lines (23) . In non-hematopoietic cells, JAK1, JAK2 and Tyk2 were phosphorylated in response to IL-13 and IL-4 in type II IL-13R bearing cells such as colon carcinoma cell lines (HT-29 and WiDr) (20) and ovarian carcinoma cell line (PA-1) (21) . On the other hand, Tyk2 and/ or JAK2 were phosphorylated in type I IL-13R bearing cells such as ovarian carcinoma cell line (IGROV-1) (21) . In all cell types, STAT6 was phosphorylated and activated in response to IL-13. These data suggest that Tyk2 is phosphorylated in all cell lines examined, but other JAK kinases were utilized depending on the expression of different IL-13R forms. It is not known which forms of IL-13R are expressed in human fibroblast cell lines and whether they utilize the same JAK-STAT pathways for signal transduction as utilized by IL-4.
In the present study, we have examined the structure of IL-13R in non-hematopoietic normal human fibroblast cell lines, and further investigated molecular mechanisms of IL-13-and IL-4-induced signal transduction.
Methods

Cells
Human skin fibroblast cell lines, sk39, sk574 and sk559, were purchased from ATCC (Rockville, MD). These cells were maintained in medium containing EMEM or DMEM with 10% FBS and 10 mM HEPES. PM-RCC human renal cell carcinoma cell line was derived from a surgical specimen and the cell line was established in our laboratory (24) . H9, a human T cell lymphoma cell line, was purchased from ATCC.
Cytokines and reagents
Recombinant human IL-13 was produced and purified as described previously (25) . Recombinant human IL-4 was kindly provided by Schering-Plough Research Institute, (Kenilworth, NJ). STAT1 and STAT5 antibodies were provided by Dr David Finbloom (CBER, FDA, Bethesda, MD). Polyclonal antibodies for JAK1, JAK2 and biotinylated-phosphotyrosine [Tyr(p), 4G10] were purchased from Upstate Biotechnology (Lake Placid, NY). IRS-1, Tyk2, JAK3 and STAT 6 (IL-4STAT) antibodies were purchased from Santa Cruz Biotechnology (Santa Cruz, CA). Anti-rabbit IgG or streptavidin horseradish peroxidase-conjugated antibodies were purchased from Amersham (Arlington Heights, IL).
RT-PCR
Total RNA was isolated using Trizol reagent (Gibco/BRL, Gaithersburg, MD). In each RT-PCR analysis, 1 µg of total RNA was incubated for 10 min at 42°C in 50 µl reaction buffer containing 10 mM Tris-HCl (pH 8.3), 5 mM MgCl 2 , 50 mM KCl, 1 mM of each dNTPs, RNase inhibitor 1 U/µl, random hexamer 2.5 µM and 2.5 U/µl of MMLV RT (Perkin-Elmer, Norwalk, CT). A 10 µl aliquot of this solution was amplified in 50 µl final volume of PCR mixture containing 10 mM Tris-HCl (pH 8.3), 2 mM MgCl 2 , 50 mM KCl, 1.25 U of AmpliTaq DNA polymerase (Perkin-Elmer) and 0.1 µg of each specific primer (15, 16, 26) . The amplification procedure performed on a temperature controller (Thermal Cycler 9600; Perkin Elmer) was as follows: after an initial denaturation step at 95°C for 2 min, 35 cycles were performed at 95°C 15 s, 60°C 30 s respectively. Then 10 µl of various PCR products was run on 2% Nusieve 3:1 agarose (FMC Bioproducts, Rockland, ME) gel for UV analysis.
Hybridization of PCR products
The identity of the PCR products of IL-13Rα and αЈ chains were confirmed by dot-blot hybridization for the amplified products with specific internal probes (IL-13R probe: ACCA-CAAGGAATTCCAG; IL-13RαЈ probe: GTTCTTCCTGATACT-TTG). The amplified products (2 µl) were applied on a nylon membrane (Nytran; S & S, Keene, NH ) and cross-linked by a UV cross-linker (UV Stratalinker 2400; Stratagene, La Jolla, CA). The membranes were hybridized with oligonucleotide probes labeled with [γ-32 P]ATP (Amersham, Arlington Height, IL). The membranes were washed in 2ϫSSC/1% SDS at 37°C for 30 min and 0.2ϫSSC/0.1% SDS at 42°C for 15 min, and exposed X-ray film for 24 h at -70°C.
Radio receptor binding assays
Recombinant human IL-13 was labeled with 125 I (Amersham) by the Iodo-Gen iodination reagent (Pierce, Rockford, IL) according to the manufacturer's instructions. The IL-13 equilibrium binding studies were performed by the method previously described (9, 21) . Briefly, adherent fibroblast cells were The cells were then lysed at 4°C with modified RIPA buffer [1% NP-40, 300 mM NaCl, 50 mM Tris (pH 7.4), leupeptin (1 mg/ml), pepstatin A (1 mg/ml), aprotinin (2 mg/ml), PMSF (20 mM), 1 mM Na vanadate, 25 mM NaF, 10 mM Na pyrophosphate and 1 mM EDTA]. The resulting lysate was analyzed by electrophoresis through SDS-PAGE (8 %) gel. The gel was dried and exposed to X-ray film for 7 days at -80°C.
Immunoprecipitation and Western Blotting
Cells (0.5ϫ10 7 ) were incubated with IL-13 (250 ng/ml) or IL-4 (50 ng/ml) for 10 min at 37°C. The reaction was quenched by adding 10 ml PBS containing 1 mM Na vanadate, 25 mM NaF, 10 mM Na pyrophosphate and 1 mM EDTA. The cells were lysed at 4°C with 1% NP-40, 300 mM NaCl, 50 mM Tris (pH 7.4), leupeptin (10 g/ml), aprotinin (10 g/ml), PMSF (2 mM), 1 mM Na vanadate, 25 mM NaF, 10 mM Na pyrophosphate and 1 mM EDTA. The lysate was precleared by incubating with Protein A-Sepharose beads (Sigma, St Louis, MO) and then incubated with Protein A-Sepharose beads that had been pre-incubated with first antibody for 2 h at 4°C. The resulting complex was washed 5 times in lysis buffer, resuspended in loading buffer and electrophoresed through 8% SDS-PAGE. Immunoprecipitated proteins were electrotransferred to PVDF membrane (Novex, San Diego, CA) for 1 h and incubated with blocking buffer (1.25% BSA, 1.25% ovalbumin, 25 mM Tris, 137 mM NaCl and 2.7 mM KCl) to block non-specific binding. The membrane was incubated with primary antibodies (1 µg/ml). The blots were washed 3 times in Trisbuffered saline Tween (TBS-T) buffer (20 mM Tris-HCl, 137 mM NaCl and 0.1% Tween 20) and then incubated for 1 h in horseradish peroxidase-conjugated goat anti-rabbit IgG or streptavidin (Amersham), depending on the nature of the primary antibody. After three washes in TBS-T buffer, blots were incubated with chemiluminescence substrate mixture (Renaissance; DuPont NEN, Boston, MA) according to the manufacturer's instructions for 1 min and exposed to X-ray film for 1-30 min.
Electrophoretic mobility shift assay (EMSA)
After incubation with IL-13 or IL-4, cells were washed with cold PBS and solubilized with a cold whole cell extraction buffer (1 mM MgCl 2 , 20 mM HEPES, pH 7.0, 10 mM KCl, 300 mM NaCl, 0.5 mM DTT, 0.1% NP-40, 1 mM PMSF, 1 mM Na vanadate and 20% glycerol). DNA protein interactions were assessed by EMSA using the Bandshift kit from Pharmacia (Piscataway, NJ). Briefly, 40 µg of sample proteins was incubated for 20 min at room temperature with 0.5 or 1 ng of 32 P-labeled double stranded oligonucleotide probe GRR (5Ј-AGCATGTTTCAAGGATTTGAGATGTATTTCCCAGAAAAG-3Ј) from the promoter of the Fcrγ1 gene in binding buffer [10 mM Tris-HCl (pH 7.5), 50 mM NaCl, 0.5 mM DTT, 10% Glycerol, 0.05% NP-40, 0.05 mg/ml poly(dI-dC)]. A 200-fold excess of cold GRR probe was added as a competitor. A ϫ10 loading dye was added to samples which were then applied to a 5% non-reducing polyacrylamide gel and run at 150 V for 2 h. Gels were dried for 2 h and autoradiographed overnights at room temperature. For the supershift assay, cell lysates were pre-incubated with STAT1, STAT5 and STAT6 antibodies on ice for 30 min; standard EMSA was then performed as described above.
Results
Expression of IL-13 receptors on human skin fibroblast cell lines
Three different normal human skin fibroblast cell lines were examined for the expression of IL-13R. As shown in Table 1 , all three cell lines bound [ 125 I]IL-13 in a specific manner. For a comparison, results from IL-13 binding on RCC cells are also shown. These cells have been shown to express highaffinity IL-13R (9). When binding data was analyzed by Scatchard analysis, a single class of high-affinity IL-13R was expressed on all fibroblast cell lines examined. The sk574 cell line displayed the highest number of IL-13R followed by sk559 and sk39. These results suggest that normal human skin fibroblast express IL-13 receptor; however, the level of IL-13R expression was different in each cell line.
Affinity cross-linking of IL-13R in normal skin fibroblast cell lines
These experiments were performed by cross-linking of [ 125 I]IL-13 to surface IL-13R complexes, followed by SDS-PAGE under reducing conditions. When equal number of cells were examined, [ 125 I]IL-13 cross-linked to a major polypeptide which migrated at~60-70 kDa on sk559 and sk574 cell lines (Fig. 1) . The pattern of binding by sk556 and sk574 cells paralleled the binding studies defined in Table 1 IL-13Rα and αЈ chains were expressed in human fibroblast cell lines Recently, we have proposed that IL-13R should be classified into three or four subtypes based on the utilization of different subunits (12) . To investigate which forms of IL-13R are expressed on normal human fibroblasts, we examined mRNA expression of both IL-13R chains, IL-4Rβ and IL-2Rγ c , by RT-PCR. As shown in Fig. 2(A) , although intensity of bands of PCR products for the IL-13Rα chain is weak in sk39 and sk559 cells, nonetheless IL-13Rα and αЈ chains were expressed in all three fibroblast cell lines examined. To confirm these results, hybridization was performed using 32 P-labeled specific internal sequence probes for IL-13Rα and αЈ chains. Again, IL-13Rα and αЈ chains were detected in all these fibroblast cell lines (Fig. 2B) . We also examined the expression of IL-4Rβ and γ c in these cell lines, and found that only the IL-4Rβ chain was expressed and γ c was not expressed in any of the fibroblast cells lines (Fig. 2A, row c and d) . PM-RCC cells served as a positive control and H9 cell line as a negative control for IL-13R expression. In PM-RCC cells, IL-13Rα and αЈ and IL-4Rβ chains were strongly expressed; however, the γ c chain was not detected like in human fibroblasts (Fig. 2A, lane 4) . On the other hand, in the H9 human T cell line only IL-13RαЈ chain was weakly detected, nevertheless IL-4Rβ and γ c chains were strongly expressed ( Fig. 2A, lane 5) .
JAK kinase phosphorylation in response to IL-13 or IL-4 in human fibroblast cell lines Next, we investigated signal transduction mechanisms through IL-13R in human normal fibroblasts. First, we examined JAK kinase phosphorylation in response to IL-13 or IL-4 in these cells. Two different normal human fibroblasts (sk574 and sk556) were stimulated by 250 ng/ml of IL-13 or 50 ng/ml of IL-4 for 10 min. Cells were lysed in lysing buffer and precleared for non-specific binding using Protein ASepharose. JAK proteins were immunoprecipitated by specific antibodies and separated by SDS-PAGE. After elec-
Fig. 2. Detection of transcripts for IL-13R and IL-4R chains by RT-PCR.
Total RNA (1 µg) was amplified as described in Methods and various PCR products were run on 2% Nusieve 3:1 agarose for UV analysis (A). The identity of the PCR products of IL-13Rα and αЈ chains was confirmed by dot-blot hybridization for the amplified products with 32 P-labeled specific internal probes (IL-13Rα probe: ACCACAAGGAATTCCAG; IL-13RαЈ probe: GTTCTTCCTGATACT-TTG). The membranes were washed and exposed to X-ray film for 24 h at -70°C (B). trical transfer to PVDF membranes, phosphorylated proteins were probed by anti-phosphotyrosine antibody. As shown in Fig. 3(A) , JAK2 was phosphorylated in response to both IL-13 and IL-4 in both cell lines. Tyk2 was constitutively phosphorylated, and its phosphorylation level was augmented in response to IL-13 and IL-4 (Fig. 3B) . Induction of phosphorylation of JAK1 kinase was more restricted. Both IL-13 and IL-4 caused strong phosphorylation of JAK1 in sk559 cells. On the other hand, JAK1 was neither expressed nor phosphorylated in sk574 cell line (Fig. 3C) . Interestingly, JAK3 protein was expressed but not phosphorylated in response to IL-13 or IL-4 in both cell lines (Fig. 3D) .
STAT6 was phosphorylated and activated in response to IL-13 in human skin fibroblasts.
To examine whether IL-13 and IL-4 induce STAT6 phosphorylation and activation in normal skin fibroblasts, we performed EMSA in these cell lines. Cells were stimulated by IL-13 or IL-4 for 10 min and lysed in a whole cell extraction buffer. Then, 20 µg of protein was incubated with 32 P-labeled GRR probes. As shown in Fig. 4(A) , both IL-4 and IL-13 induced STAT activation in these cell lines. To determine which STAT protein was activated, we performed a 'supershift' assay utilizing a mAb to STAT1, STAT5 and STAT6 proteins. We found that only anti-STAT6 antibody caused a further shift in the band in response to IL-13 (Fig. 4B, lane 3) , indicating that the activated protein is indeed STAT6. We also examined the phosphorylation status of immunoprecipitated STAT6 protein. As shown in Fig. 4(C) , STAT6 was strongly phosphorylated in response to IL-13 or IL-4 in these cell lines.
IRS-1 protein was phosphorylated in response to IL-13 or IL-4 in normal skin fibroblast cell lines
It has been previously demonstrated that both IL-4 and IL-13 can activate IRS-1 pathways in various cell types (10, (18) (19) (20) (21) (22) . We therefore investigated whether IRS-1 protein was also utilized in IL-4/IL-13R signal transduction system in normal human skin fibroblast cell lines. As shown in Fig. 5 , IRS-1 protein was constitutively phosphorylated, although faintly, in the studied fibroblast cell lines and this phosphorylation level was augmented in response to IL-13 or IL-4.
Discussion
In this report, we have examined the structure and signal transduction through IL-13 receptors in normal human skin fibroblast cell lines. We demonstrate for the first time that human skin fibroblast cell lines express high-affinity IL-13R and [ 125 I]IL-13 cross-links to a single broad band of~60-70 kDa in these cell lines. We further demonstrate that fibroblast cell lines express mRNA for IL-13Rα and αЈ chains. Thus, it is reasonable to speculate that this broad band includes two known proteins of the IL-13R system. We also report that JAK2, Tyk2, STAT6 and IRS-1 proteins were phosphorylated in response to both IL-13 and IL-4. The phosphorylation of JAK1 was restricted and in only one of the two cell lines examined JAK1 was phosphorylated in response to IL-13 or IL-4.
The detailed structural analysis of IL-13 receptors by RT-PCR and dot-blot hybridization revealed that all three fibroblast cell lines examined expressed IL-13Rα, αЈ and IL-4Rβ chains. However, γ c chain was not expressed. The number of IL-13 binding sites per cell correlated with the level of mRNA expression for the IL-13Rα chain. For example, the expression of the IL-13Rα chain in sk39 and sk559 cell lines was lower compared to the sk574 cell line which expressed the highest level of IL-13R. The results of RT-PCR and dot-blot hybridization experiments were confirmed at the protein level by affinity cross-linking analysis. Two fibroblast cell lines examined cross-linked to a broad band of~60-70 kDa (after subtraction of molecular mass of IL-13, 12 kDa). The size of this protein is similar to that previously reported for human RCC, ovarian carcinoma and glioblastoma cell lines (9, 12, 17, 21) . These results indicate that characteristics of IL-13R in normal human fibroblast cell lines are quite similar to those found in RCC and glioblastoma cell lines. Consistent with higher binding as seen in Table 1 , the intensity of [ 125 I]IL-13 binding to the~60-70 kDa band in sk574 was higher compared to sk559. In contrast to expression of the IL-4R chain, no cross-linking of [ 125 I]IL-13 was observed to the p140 chain indicating that the IL-4R chain is not a major component of the IL-13R complex despite the message for IL-4R chain was expressed. Our results thus suggest that the broad band at~60-70 kDa may be composed of two isomers of IL-13R (IL-13Rα and αЈ) as previously proposed (12) . Although IL-4R is also expressed in these cells, it does not seem to participate in the formation of IL-13R complex in fibroblasts. The IL-4R chain may still participate in the signal transduction pathway induced by IL-13 because as shown previously, IL-13Rα and αЈ subunits cannot signal on their own; they require additional accessory molecules such as IL-4Rβ for signal transduction (Murata et al., unpublished data) . The availability of mAb to IL-13R chains in the future will most likely shed some additional light on IL-13R structure.
We next demonstrated that JAK2 and Tyk2 (also JAK1 in sk559) were phosphorylated in response to IL-13 or IL-4 in normal skin fibroblasts. Previously, we reported that JAK2 and Tyk2 were phosphorylated in response to IL-13 or IL-4 in the IGROV-1 cell line, which expresses type I IL-13 receptors (21), and JAK1, JAK2 and Tyk2 were phosphorylated in PA-1, HT-29 and WiDr cell lines, which express type II IL-13R (20, 21) . In hematopoietic cells which express type III IL-13R, e. g. TF-1 and EBV-B cells, Tyk2 and/or JAK1 were phosphorylated in response to IL-13. However, in these hematopoietic cells, JAK1, JAK3 and Tyk2 were phosphorylated in response to IL-4 (22, 26) . These results suggest that Tyk2 kinase is phosphorylated in every cell line examined. Because the IL-13RαЈ chain is present in all these types of IL-13R, our data suggest that Tyk2 may associate with the IL-13RαЈ chain.
Although a variety of JAK kinases are phosphorylated in response to cytokines in various cell types, STAT6 is phosphorylated and activated in response to only IL-13 and IL-4 (11, 20, 21, 23) . It has been reported that in STAT6 knockout mice, all immune functions except IL-4-and IL-13-induced proliferation were disrupted in lymphocytes (27, 28) and monocytes (29) . Since STAT6 is utilized in IL-13R and IL-4R signaling in normal human skin fibroblasts, our data suggest that STAT6 may also play an important role in the IL-4/13 receptor system in non-hematopoietic cell lines. It will be of interest to examine the effect of IL-4 and IL-13 on fibroblast function from STAT6 knockout animals.
Similar to STAT6, IRS-1 protein was phosphorylated in response to IL-13 or IL-4 in these cell lines. In mouse hematopoietic cells, the IRS-1 pathway was shown to be required for the proliferative effect of IL-4 (19) . Previously, we and other groups reported that IL-13 and IL-4 have growth inhibitory effects in breast cancer (30) , RCC (24, 31) and human B cell leukemia cell lines (32) . Although IL-4 or IL-13 had a growth inhibitory effect in colon cancer cell lines, the IRS-1 pathway was still activated (10, 20) . Moreover, IRS-1 protein was phosphorylated in response to IL-4 or IL-13 in human fibroblasts even though IL-4 or IL-13 did not affect the cell growth in these cell lines (data not shown). Thus, an IRS-1 pathway induced by IL-4 or IL-13 may not necessarily contribute to cell growth in non-hematopoietic cells.
The significance of IL-13R and IL-4R expression on human fibroblast cell lines is not completely clear. It has been reported that IL-4 can induce chemotaxis (3), synthesis of extracellular matrix protein (4) and proliferation of fibroblast cell lines (2) . In addition, both IL-4 and IL-13 can induce complement C3 protein synthesis and a decrease in factor B synthesis in tumor necrosis factor-stimulated human fibroblasts (5) . Whether IL-13 can also cause chemotaxis and synthesis of extracellular matrix protein is not clear. However, based on the above reports it is suggested that IL-4R and to some extent IL-13R may regulate local inflammatory and allergic response, and may help wound healing.
In summary, we have demonstrated for the first time that high-affinity IL-13R are expressed in normal human skin fibroblast cell lines. The high affinity IL-13R appears to be composed of IL-13Rα and αЈ chains, although mRNA for IL-4Rβ but not γ c chain was also detected. Furthermore, JAK2, Tyk2 and in some cases JAK1 tyrosine kinases and IRS-1 proteins were phosphorylated in response to IL-13 or IL-4. STAT6 protein was also phosphorylated and activated in response to both cytokines. These results suggest that expression of IL-13Rα and αЈ chains and phosphorylation of JAK2 kinase in response to IL-13 or IL-4 are not cancer cell specific-normal human fibroblasts share these characteristics. Because both IL-4 and IL-13 have similar effects in normal fibroblasts, our data support the notion that identical signaling may be responsible, at least in part, for their redundant effects.
